• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    CTI BioPharma Corp. (CTIC)

    -NasdaqCM
    2.34 Down 0.04(1.68%) 4:00PM EST
    |After Hours : 2.34 Down 0.00 (0.01%) 4:39PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:2.38
    Open:2.35
    Bid:2.28 x 1200
    Ask:2.34 x 100
    1y Target Est:5.08
    Beta:1.64
    Next Earnings Date:12-Mar-15CTIC Earnings announcement
    Day's Range:2.32 - 2.36
    52wk Range:2.00 - 4.22
    Volume:1,577,144
    Avg Vol (3m):1,728,640
    Market Cap:339.62M
    P/E (ttm):N/A
    EPS (ttm):-0.30
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CTIC

    Comparison

    Symbol% ChgMkt Cap
    CTICDown 1.68%339.62M
    BMYDown 0.88%101.26B
    RHHBYUp 0.80%191.83B
    SNYDown 0.02%128.58B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):4.60
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.54
    Quarterly EPS Est (Dec-14) :-0.18
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    CTI BioPharma Corp., a biopharmaceutical company, is engaged in the acquisition, development, and commercialization of treatments for cancer. It primarily focuses on the commercialization of PIXUVRI, an aza-anthracenedione derivative, which is in ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback